Yoshie Tsujimoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yoshie Tsujimoto has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Manabu Suzuki
Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan
4 shared publications Jin Takasaki
3 shared publications- Masayuki Hojo
Division of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan
3 shared publications - Yusaku Kusaba
Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan
3 shared publications Akane Ishida
2 shared publicationsAkinari Tsukada
Department of Respiratory Medicine, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan
2 shared publications
Latest Publications
- 9 November 2024
- Published by Elsevier in Respiratory Investigation
- Vol. 62 (6) , 1227-1232
Preliminary investigation of the significance of cavitary lesions in recurrent hemoptysis following bronchial artery embolization for nontuberculous mycobacterial pulmonary disease
- 9 November 2024
- Published by Elsevier in Respiratory Investigation
- Vol. 62 (6) , 1227-1232
Preliminary investigation of the significance of cavitary lesions in recurrent hemoptysis following bronchial artery embolization for nontuberculous mycobacterial pulmonary disease
- Open Access
- 23 April 2023
- Published by Elsevier in Respiratory Investigation
- Vol. 61 (4) , 405-408
A case of idiopathic multicentric Castleman disease with pulmonary hyalinizing granuloma-like multiple pulmonary nodules
- 23 April 2023
- Published by Elsevier in Respiratory Investigation
- Vol. 61 (4) , 405-408
Open AccessA case of idiopathic multicentric Castleman disease with pulmonary hyalinizing granuloma-like multiple pulmonary nodules
- Open Access
Diagnostic Value of Bronchoscopy for Peripheral Metastatic Lung Tumors
Although lungs are one of the most frequent sites of metastasis for malignant tumors, little has been reported about the value of bronchoscopy for lung metastases presenting with peripheral pulmonary lesions (PPLs). This retrospective cohort study investigated the diagnostic value of bronchoscopy for peripheral metastatic lung tumors. Consecutive patients who underwent diagnostic bronchoscopy with radial endobronchial ultrasound for PPLs and were finally diagnosed with metastatic lung tumors from April 2012 to March 2019 were included. We analyzed 235 PPLs, with a median size of 18.8 mm. The overall diagnostic yield was 76.6%. In a multivariable analysis, large lesion size (>20.0 mm vs. p = 0.043, OR = 2.26), inner location (inner 2/3 vs. outer 1/3: 84.8% vs. 69.1%, p = 0.004, OR = 2.79), and visibility on radiography (visible vs. invisible: 83.2% vs. 56.1%, p = 0.015, OR = 3.29) significantly affected the diagnostic yield. Although a positive bronchus sign tended to have a higher yield, no significant difference was observed (81.8% vs. 70.6%, p = 0.063). Only one case of lung abscess was observed, with no serious complications. In conclusion, bronchoscopy is a valuable technique for peripheral metastatic lung tumors, with good diagnostic accuracy and safety.
Open AccessDiagnostic Value of Bronchoscopy for Peripheral Metastatic Lung Tumors
Although lungs are one of the most frequent sites of metastasis for malignant tumors, little has been reported about the value of bronchoscopy for lung metastases presenting with peripheral pulmonary lesions (PPLs). This retrospective cohort study investigated the diagnostic value of bronchoscopy for peripheral metastatic lung tumors. Consecutive patients who underwent diagnostic bronchoscopy with radial endobronchial ultrasound for PPLs and were finally diagnosed with metastatic lung tumors from April 2012 to March 2019 were included. We analyzed 235 PPLs, with a median size of 18.8 mm. The overall diagnostic yield was 76.6%. In a multivariable analysis, large lesion size (>20.0 mm vs. p = 0.043, OR = 2.26), inner location (inner 2/3 vs. outer 1/3: 84.8% vs. 69.1%, p = 0.004, OR = 2.79), and visibility on radiography (visible vs. invisible: 83.2% vs. 56.1%, p = 0.015, OR = 3.29) significantly affected the diagnostic yield. Although a positive bronchus sign tended to have a higher yield, no significant difference was observed (81.8% vs. 70.6%, p = 0.063). Only one case of lung abscess was observed, with no serious complications. In conclusion, bronchoscopy is a valuable technique for peripheral metastatic lung tumors, with good diagnostic accuracy and safety.
- Open Access
- 24 March 2021
- Published by Taylor & Francis in Infectious Diseases
- Vol. 53 (8) , 581-589
Diagnostic accuracy of nasopharyngeal swab, nasal swab and saliva swab samples for the detection of SARS-CoV-2 using RT-PCR
The current gold standard in coronavirus disease (COVID-19) diagnostics is the real-time reverse transcription–polymerase chain reaction (RT-PCR) assay for detecting severe acute respiratory syndro...
- 24 March 2021
- Published by Taylor & Francis in Infectious Diseases
- Vol. 53 (8) , 581-589
Open AccessDiagnostic accuracy of nasopharyngeal swab, nasal swab and saliva swab samples for the detection of SARS-CoV-2 using RT-PCR
The current gold standard in coronavirus disease (COVID-19) diagnostics is the real-time reverse transcription–polymerase chain reaction (RT-PCR) assay for detecting severe acute respiratory syndro...
- Open Access
- 1 January 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 104, 65-72
Utility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of disease transmission
- 1 January 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 104, 65-72
Open AccessUtility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of disease transmission
- 28 September 2019
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 54 (suppl 63) , PA3112
Diagnostic value of bronchoscopy for peripheral metastatic lung tumors
When we encounter cases with peripheral pulmonary lesions (PPLs) through cancer therapies, the pathological diagnosis is crucial to determine an accurate treatment plan. However, diagnostic bronchoscopy for metastatic lung tumors tends to have a difficult impression. Thus, we investigated the diagnostic value of bronchoscopy in this situation. Consecutive cases who underwent diagnostic bronchoscopy with radial endobronchial ultrasound (R-EBUS) for PPLs from April 2012 to March 2017 were collected. Among them, the cases finally diagnosed as metastatic lung tumor were enrolled. The diagnostic outcome and the factors affecting it were analyzed; including factors were age, sex, lesion size/lobe/location, bronchus sign, distance from costal pleura, visibility on X-ray and use of navigation/guide sheath/needle. We analyzed 179 cases; the median (range) lesion size was 19.5 (6.0-80.8) mm, and 75 cases showed negative bronchus sign. The overall diagnostic yield was 71.5%; there was a significant difference depend on EBUS images (within vs. adjacent to vs. invisible: 92.3% vs. 67.9% vs. 17.4%, p20.0 mm vs. p=0.017); location (inner 2/3 vs. outer 1/3: 82.4% vs. 61.4%, p=0.024); visibility on X-ray (visible vs. invisible: 78.2% vs. 54.3%, p=0.042). Although bronchus sign is known as the most important factors, there was no significant difference in this situation (positive vs. negative: 77.9% vs. 64.0%, p=0.108). In conclusion, diagnostic bronchoscopy for peripheral metastatic lung tumors is similar to it for primary lung cancers except for the contribution of bronchus sign.
- 28 September 2019
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 54 (suppl 63) , PA3112
Diagnostic value of bronchoscopy for peripheral metastatic lung tumors
When we encounter cases with peripheral pulmonary lesions (PPLs) through cancer therapies, the pathological diagnosis is crucial to determine an accurate treatment plan. However, diagnostic bronchoscopy for metastatic lung tumors tends to have a difficult impression. Thus, we investigated the diagnostic value of bronchoscopy in this situation. Consecutive cases who underwent diagnostic bronchoscopy with radial endobronchial ultrasound (R-EBUS) for PPLs from April 2012 to March 2017 were collected. Among them, the cases finally diagnosed as metastatic lung tumor were enrolled. The diagnostic outcome and the factors affecting it were analyzed; including factors were age, sex, lesion size/lobe/location, bronchus sign, distance from costal pleura, visibility on X-ray and use of navigation/guide sheath/needle. We analyzed 179 cases; the median (range) lesion size was 19.5 (6.0-80.8) mm, and 75 cases showed negative bronchus sign. The overall diagnostic yield was 71.5%; there was a significant difference depend on EBUS images (within vs. adjacent to vs. invisible: 92.3% vs. 67.9% vs. 17.4%, p20.0 mm vs. p=0.017); location (inner 2/3 vs. outer 1/3: 82.4% vs. 61.4%, p=0.024); visibility on X-ray (visible vs. invisible: 78.2% vs. 54.3%, p=0.042). Although bronchus sign is known as the most important factors, there was no significant difference in this situation (positive vs. negative: 77.9% vs. 64.0%, p=0.108). In conclusion, diagnostic bronchoscopy for peripheral metastatic lung tumors is similar to it for primary lung cancers except for the contribution of bronchus sign.